Invention Grant
- Patent Title: Methods of treating lung cancer
-
Application No.: US16003590Application Date: 2018-06-08
-
Publication No.: US10537611B2Publication Date: 2020-01-21
- Inventor: Thomas Harding , Servando Palencia , Li Long , Kevin Hestir
- Applicant: Five Prime Therapeutics, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Five Prime Therapeutics, Inc.
- Current Assignee: Five Prime Therapeutics, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: McNeill Baur PLLC
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K45/06 ; A61K39/395 ; A61K45/00 ; C07K14/71 ; C12Q1/6813 ; C12Q1/686 ; G01N33/50
Abstract:
Methods of treating cancers comprising FGFR1 gene amplification are provided. In some embodiments, the methods comprise administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule. In some embodiments, the methods comprise administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and/or an FGFR1 ECD fusion molecule in combination with at least one additional therapeutic agent.
Public/Granted literature
- US20190000920A1 Methods of Treating Cancer Public/Granted day:2019-01-03
Information query
IPC分类:
